FIELD: pharmaceutics. SUBSTANCE: the method deals with transbuccal delivery system of medicinal preparation in the form of slowly dissolving lozenge consisted of soluble filler at the quantity of 50-99 weight%, nonsoluble filmforming agent, swelling polymer and, at least, one active substance and additional ones. The present lozenge enables to perform delivery for the more prolonged period of time. EFFECT: higher efficiency of delivery. 10 cl, 1 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TABLETTED CHEWING GUMS | 2009 |
|
RU2501551C2 |
| TABLETS WITH COVER | 2004 |
|
RU2362549C2 |
| PASTILLE DOZED FORM | 2018 |
|
RU2771806C2 |
| PHARMACEUTICAL COMPOSITION INCLUDING DICLOFENAC | 2005 |
|
RU2424793C2 |
| LAMINAR DRUG DELIVERY DEVICE | 2011 |
|
RU2594064C2 |
| MULTICOMPONENT ORAL DOSAGE FORM WITH ORGANOLEPTIC PROPERTIES | 2010 |
|
RU2490010C2 |
| FILMS, DISSOLVING IN MOUTH CAVITY | 2004 |
|
RU2351315C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING S1P RECEPTOR MODULATOR | 2007 |
|
RU2487703C2 |
| NICOTINE COMPOSITION FOR PERORAL APPLICATION, WHICH CONTAINS AMINO-ACID BUFFER | 2008 |
|
RU2465904C2 |
| SOLID NICOTINE-CONTAINING DOSAGE FORM WITH REDUCED UNPLEASANT ORGANOLEPTIC IMPACT | 2013 |
|
RU2623018C2 |
